Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action
Open Access
- 1 November 2005
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 125 (5), 1045-1052
- https://doi.org/10.1111/j.0022-202x.2005.23925.x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Histone deacetylase inhibitors – a new tool to treat cancerCancer Treatment Reviews, 2004
- The Novel Synthetic Oleanane Triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) Induces Apoptosis in Mycosis Fungoides/Sézary Syndrome CellsJournal of Investigative Dermatology, 2004
- T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistanceBlood, 2004
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- Emerging roles of caspase-3 in apoptosisCell Death & Differentiation, 1999
- P210 and P190 Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family MembersJournal of Biological Chemistry, 1996
- Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptorInternational Journal of Cancer, 1991
- Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)Science, 1983
- Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factorThe Journal of Experimental Medicine, 1981